InspireMD, Inc. (NSPR) stock
NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 10/3054% below fair value
$0.64−0.13 (-16.78%)
Close on Nov 13, 2026Market cap $29.94MP/E –Yield –
InspireMD profit margin
Profit margin (net margin) is net income as a percentage of revenue.
InspireMD's profit margin for the twelve months ending Jun 30, 2026 was -484.1%. For fiscal 2025 it was -543.3%, against -456.6% the year before. The highest annual figure on record is -69.1% in fiscal 2010.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -543.3% | −86.7 |
| FY2024 | Dec 31, 2024 | -456.6% | −135.7 |
| FY2023 | Dec 31, 2023 | -321.0% | +36.6 |
| FY2022 | Dec 31, 2022 | -357.6% | −25.7 |
| FY2021 | Dec 31, 2021 | -331.9% | +92.4 |
| FY2020 | Dec 31, 2020 | -424.3% | −154.5 |
| FY2019 | Dec 31, 2019 | -269.8% | −68.8 |
| FY2018 | Dec 31, 2018 | -201.1% | +104.6 |
| FY2017 | Dec 31, 2017 | -305.6% | +141.1 |
| FY2016 | Dec 31, 2016 | -446.7% | +227.9 |
| FY2015 | Dec 31, 2015 | -674.7% | −74.3 |
| FY2013 | Jun 30, 2013 | -600.4% | −531.3 |
| FY2010 | Dec 31, 2010 | -69.1% | +10.8 |
| FY2009 | Dec 31, 2009 | -79.9% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -808.8% | −69.2 |
| Q1 FY2026 | Mar 31, 2026 | -402.9% | +327.4 |
| Q4 FY2025 | Dec 31, 2025 | -373.5% | +97.2 |
| Q3 FY2025 | Sep 30, 2025 | -503.7% | −67.8 |
| Q2 FY2025 | Jun 30, 2025 | -739.7% | −284.8 |
| Q1 FY2025 | Mar 31, 2025 | -730.3% | −264.9 |
| Q4 FY2024 | Dec 31, 2024 | -470.7% | −163.8 |
| Q3 FY2024 | Sep 30, 2024 | -435.9% | −103.1 |
| Q2 FY2024 | Jun 30, 2024 | -454.8% | −146.9 |
| Q1 FY2024 | Mar 31, 2024 | -465.4% | −121.9 |
| Q4 FY2023 | Dec 31, 2023 | -306.9% | +165.3 |
| Q3 FY2023 | Sep 30, 2023 | -332.8% | −16.3 |
| Q2 FY2023 | Jun 30, 2023 | -307.9% | −5.1 |
| Q1 FY2023 | Mar 31, 2023 | -343.5% | +35.3 |
| Q4 FY2022 | Dec 31, 2022 | -472.2% | −175.3 |
| Q3 FY2022 | Sep 30, 2022 | -316.5% | +63.6 |
| Q2 FY2022 | Jun 30, 2022 | -302.8% | +35.1 |
| Q1 FY2022 | Mar 31, 2022 | -378.8% | −56.4 |
| Q4 FY2021 | Dec 31, 2021 | -296.9% | +2141.7 |
| Q3 FY2021 | Sep 30, 2021 | -380.1% | −152.3 |
| Q2 FY2021 | Jun 30, 2021 | -337.9% | +454.5 |
| Q1 FY2021 | Mar 31, 2021 | -322.4% | −131.1 |
| Q4 FY2020 | Dec 31, 2020 | -2438.6% | −2186.2 |
| Q3 FY2020 | Sep 30, 2020 | -227.9% | −7.4 |
| Q2 FY2020 | Jun 30, 2020 | -792.3% | −629.4 |
| Q1 FY2020 | Mar 31, 2020 | -191.3% | +581.5 |
| Q4 FY2019 | Dec 31, 2019 | -252.4% | +16.8 |
| Q3 FY2019 | Sep 30, 2019 | -220.4% | +41.1 |
| Q2 FY2019 | Jun 30, 2019 | -162.9% | −100.4 |
| Q1 FY2019 | Mar 31, 2019 | -772.8% | −535.5 |
| Q4 FY2018 | Dec 31, 2018 | -269.2% | −89.5 |
| Q3 FY2018 | Sep 30, 2018 | -261.5% | +29.0 |
| Q2 FY2018 | Jun 30, 2018 | -62.5% | +295.9 |
| Q1 FY2018 | Mar 31, 2018 | -237.2% | +212.5 |
| Q4 FY2017 | Dec 31, 2017 | -179.7% | +524.6 |
| Q3 FY2017 | Sep 30, 2017 | -290.5% | +134.8 |
| Q2 FY2017 | Jun 30, 2017 | -358.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -449.7% | – |
| Q4 FY2016 | Dec 31, 2016 | -704.3% | – |
| Q3 FY2016 | Sep 30, 2016 | -425.4% | – |
See a number that looks wrong?